Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03630120Phase 2Terminated
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
Differentiated Thyroid CancerFollicular Thyroid CancerPapillary Thyroid Cancer+3 more
PrincipalinvestigatorStart date: 2018-08-06
NCT03370276Phase 1/2Completed
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
Head and Neck CarcinomaHead and Neck Squamous Cell CarcinomaSquamous Cell Cancer+5 more
PrincipalinvestigatorStart date: 2017-12-20

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Kong Y Chen, Ph.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
11 trials

Shared therapeutic areas:

Follicular Thyroid CancerThyroid Cancer, Papillary
Similarity Score4%

Anurag K Singh

Roswell Park Cancer Institute

Related
8 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckHead and Neck Carcinoma
Similarity Score4%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckThyroid Carcinoma
Similarity Score4%

Naris Nilubol, M.D.

National Cancer Institute (NCI)

Related
10 trials

Shared therapeutic areas:

Differentiated Thyroid CancerThyroid Carcinoma
Similarity Score4%

Anurag Singh

Roswell Park Cancer Institute

Related
10 trials

Shared therapeutic areas:

Head and Neck CarcinomaSquamous Cell Carcinoma of Head and Neck
Similarity Score4%

Matthew Krebs, Dr

The Christie Hospital

Related
7 trials

Shared therapeutic areas:

Thyroid Cancer, Papillary
Similarity Score2%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Follicular Thyroid Cancer
Similarity Score2%

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and Neck
Similarity Score2%

Alan Ho, MD, PhD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Thyroid Carcinoma

Worked with same sponsors:

Bristol-Myers Squibb
Similarity Score2%

Arya Amini

City of Hope Medical Center

Related
7 trials

Shared therapeutic areas:

Head and Neck Carcinoma
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03630120Phase 2PrincipalInvestigator

Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer

Differentiated Thyroid CancerFollicular Thyroid CancerPapillary Thyroid Cancer+3 more
Terminated
NCT03370276Phase 1/2PrincipalInvestigator

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Head and Neck CarcinomaHead and Neck Squamous Cell CarcinomaSquamous Cell Cancer+5 more
Completed

All 2 trials loaded